The Golden West Chapter Congratulates the 2013 Sheila Essey Award
for ALS Research and the Richard Olney MD,
Clinician-Scientist Development Award Receipents
March 7, 2013 —
|
Sheila Essey, with her husband Dick Essey
|
|
Richard K. Olney appearing in a public service announcement for The ALS Association
|
The Sheila Essey Award for ALS Research
In 1996, The ALS Association, in partnership with
the American Academy of Neurology, inaugurated the Sheila Essey Award for ALS
Research to acknowledge and honor an individual who is actively engaged and
making significant contributions in research for the cause, treatment,
prevention or cure of ALS. The recipient receives a $25,000 prize to be used
specifically for continuing his/her ALS research. Funding of the award is made
possible through The Essey Family Fund and The ALS Association. Richard Essey,
Sheila's husband, served as a National Trustee of The ALS Association and is
one of the founders of The Golden West Chapter.
The ALS Association joins the American Academy of
Neurology in presenting the 2013 Sheila Essey Award for ALS Research to two
clinician-scientists who have significantly impacted clinical trials,
epidemiology and genetics in ALS: Rosa Rademakers, PhD of Jacksonville, FL and Bryan Traynor, MD of Bethesda, MD.
For more information about the honoree, plase click here.
The Richard Olney, MD, Clinician-Scientist Development Award
In February 2012, the American Academy of Neurology
Foundation and The ALS Association announced the creation of the Richard Olney,
MD, Clinician-Scientist Development Award in ALS, named after Richard K. Olney, MD, a leading neurologist and pioneer in clinical ALS research who died in
January 2012.
Olney was the founder and Director of the ALS
Treatment and Research Center at the University of California-San Francisco
before he was diagnosed with ALS in 2004. In 2006, the American Academy of
Neurology Foundation presented Olney with a special Public Education Award and
money for research in recognition of his efforts to raise awareness of ALS by
sharing his story as a researcher/doctor turned patient with the national
media.
“We came together to create this research
fellowship in record time as a tribute to Dr. Olney, not only as a courageous
person, but one whose pioneering ALS research improved the lives of many people
diagnosed with this dreadful disease that gradually robs the body of its
ability to use its muscles,” said John Mazziotta, MD, PhD, Chair of the
American Academy of Neurology Foundation’s Board of Trustees and Professor and
Chair of UCLA’s Brain Mapping Center in Los Angeles.
“The loss to our ALS community is immeasurable,”
said Fred Fisher, President and CEO of The ALS Association Golden West Chapter.
“Dr. Olney's commitment to excellence in patient care, clinical research and
advocacy has contributed to people with ALS living longer, better quality lives.”
The 2013 Richard Olney, MD Clinician-Scientist
Development Three-Year Award will be given to James Berry, MD, MPH of Massachusetts General Hospital.
Developed as part of The ALS Association's research
program TREAT ALS (Translational Research Advancing Therapy for ALS), the award
aims to recognize the importance of good clinical research and encourage young
investigators in clinical studies. Funding of the award is made possible
through The ALS Association and the American Brain Foundation.
For more information about the honoree, please click here.
|